-
1
The meta-analysis evaluated the efficacy and safety of parathyroid hormone (PTH) analogs compared to conventional therapy for hypoparathyroidism.
-
2
Eleven studies were included, showing no significant differences in serum calcium, serum phosphorus, or 24-hour urinary calcium excretion between therapies.
-
3
PTH analogs therapy decreased serum 25(OH) vitamin D, increased 1,25(OH)2 vitamin D, and improved estimated glomerular filtration rate (eGFR).
-
4
PTH analogs significantly improved health-related quality of life (HRQoL) as measured by the SF-36 Health Survey Questionnaire.
-
5
The study indicates that PTH analogs may offer comparable control of serum calcium and phosphorus while enhancing vitamin D regulation and HRQoL.
